{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31081045", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "30"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.3892/ijo.2019.4777"], "Journal": {"ISSN": "1791-2423", "JournalIssue": {"Volume": "54", "Issue": "6", "PubDate": {"Year": "2019", "Month": "Jun"}}, "Title": "International journal of oncology", "ISOAbbreviation": "Int J Oncol"}, "ArticleTitle": "Harmine induces anticancer activity in breast cancer cells via targeting TAZ.", "Pagination": {"StartPage": "1995", "EndPage": "2004", "MedlinePgn": "1995-2004"}, "Abstract": {"AbstractText": ["Harmine (HM) is a \u03b2\u2011carboline alkaloid found in multiple medicinal plants. It has been used in folk medicine for anticancer therapy; however, the molecular mechanism of HM on human breast cancer remains unclear. Transcriptional co\u2011activator with PDZ\u2011binding motif (TAZ), also known as WW domain\u2011containing transcription regulator\u00a01, serves an important role in the carcinogenesis and progression of breast cancer. The aim of the present study was to elucidate the potential anticancer activity and mechanism of HM in breast cancer, in\u00a0vitro and in\u00a0vivo. Cell proliferation was measured using a CCK\u20118 assay, apoptotic activity was detected by flow cytometry and DAPI staining, and cell migration was examined using a wound healing assay. The expression of proteins, including extracellular signal\u2011regulate kinase (Erk), phosphorylated (p\u2011) Erk, protein kinase B (Akt), p\u2011Akt, B\u2011cell lymphoma\u00a02 (Bcl\u20112) and Bcl\u20112\u2011associated X protein (Bax), were determined by western blotting. The mRNA expression of TAZ was detected using reverse transcription\u2011quantitative polymerase chain reaction analysis. The expression of proteins in mouse tumor tissues were examined by immunohistochemistry. HM significantly suppressed cellular proliferation and migration, promoted apoptosis in\u00a0vitro and inhibited tumor growth in\u00a0vivo. In addition, HM significantly decreased the expression of TAZ, p\u2011Erk, p\u2011Akt and Bcl\u20112, but increased that of Bax. The overexpression of TAZ in breast cancer cells inhibited the antitumor effect of HM. In conclusion, HM was found to induce apoptosis and prevent the proliferation and migration of human breast cancer cell lines, possibly via the downregulation of TAZ."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Ding", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "He", "ForeName": "Jinrong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Huang", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Chinese Medicine, Humanwell Healthcare (Group) Co., Ltd., Wuhan, Hubei 430075, P.R. China."}], "LastName": "Yu", "ForeName": "Tong", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Shi", "ForeName": "Xiaoyan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Zhang", "ForeName": "Tianzhu", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Yan", "ForeName": "Ge", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Chen", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China."}], "LastName": "Peng", "ForeName": "Caixia", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Int J Oncol", "NlmUniqueID": "9306042", "ISSNLinking": "1019-6439"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Trans-Activators"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcriptional Coactivator with PDZ-Binding Motif Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "WWTR1 protein, human"}, {"RegistryNumber": "4FHH5G48T7", "NameOfSubstance": "Harmine"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Harmine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Intracellular Signaling Peptides and Proteins"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Trans-Activators"}, {"QualifierName": [], "DescriptorName": "Transcription Factors"}, {"QualifierName": [], "DescriptorName": "Transcriptional Coactivator with PDZ-Binding Motif Proteins"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330. doi: 10.3322/caac.21332.", "ArticleIdList": ["10.3322/caac.21332", "26742998"]}, {"Citation": "Chang L, Weiner LS, Hartman SJ, Horvath S, Jeste D, Mischel PS, Kado DM. Breast cancer treatment and its effects on aging. J Geriatr Oncol. 2019;10:346\u2013355. doi: 10.1016/j.jgo.2018.07.010.", "ArticleIdList": ["10.1016/j.jgo.2018.07.010", "PMC7062379", "30078714"]}, {"Citation": "Nathanson KL, Domchek SM. Therapeutic approaches for women predisposed to breast cancer. Annu Rev Med. 2011;62:295\u2013306. doi: 10.1146/annurev-med-010910-110221.", "ArticleIdList": ["10.1146/annurev-med-010910-110221", "21034216"]}, {"Citation": "Patel K, Gadewar M, Tripathi R, Prasad SK, Patel DK. A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid \u2018Harmine\u2019. Asian Pac J Trop Biomed. 2012;2:660\u2013664. doi: 10.1016/S2221-1691(12)60116-6.", "ArticleIdList": ["10.1016/S2221-1691(12)60116-6", "PMC3609365", "23569990"]}, {"Citation": "Berrougui H, Mart\u00edn-Cordero C, Khalil A, Hmamouchi M, Ettaib A, Marhuenda E, Herrera MD. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. Pharmacol Res. 2006;54:150\u2013157. doi: 10.1016/j.phrs.2006.04.001.", "ArticleIdList": ["10.1016/j.phrs.2006.04.001", "16750635"]}, {"Citation": "Chen Q, Chao R, Chen H, Hou X, Yan H, Zhou S, Peng W, Xu A. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer. 2005;114:675\u2013682. doi: 10.1002/ijc.20703.", "ArticleIdList": ["10.1002/ijc.20703", "15609303"]}, {"Citation": "Zhang H, Sun K, Ding J, Xu H, Zhu L, Zhang K, Li X, Sun W. Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclo-oxygenase-2 expression in gastric cancer. Phytomedicine. 2014;21:348\u2013355. doi: 10.1016/j.phymed.2013.09.007.", "ArticleIdList": ["10.1016/j.phymed.2013.09.007", "24176842"]}, {"Citation": "Dai F, Chen Y, Song Y, Huang L, Zhai D, Dong Y, Lai L, Zhang T, Li D, Pang X, et al. A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. PLoS One. 2012;7:e52162. doi: 10.1371/journal.pone.0052162.", "ArticleIdList": ["10.1371/journal.pone.0052162", "PMC3531399", "23300602"]}, {"Citation": "Li C, Wang Y, Wang C, Yi X, Li M, He X. Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells. Phytomedicine. 2017;28:10\u201318. doi: 10.1016/j.phymed.2017.02.008.", "ArticleIdList": ["10.1016/j.phymed.2017.02.008", "28478808"]}, {"Citation": "Abe A, Yamada H. Harmol induces apoptosis by caspase-8 activation independently of Fas/Fas ligand interaction in human lung carcinoma H596 cells. Anticancer Drugs. 2009;20:373\u2013381. doi: 10.1097/CAD.0b013e32832a2dd9.", "ArticleIdList": ["10.1097/CAD.0b013e32832a2dd9", "19318910"]}, {"Citation": "Hashemi Sheikh, Shabani S, Seyed Hasan, Tehrani S, Rabiei Z, Tahmasebi Enferadi S, Vannozzi GP. Peganum harmala L.'s anti-growth effect on a breast cancer cell line. Biotechnol Rep (Amst) 2015;8:138\u2013143. doi: 10.1016/j.btre.2015.08.007.", "ArticleIdList": ["10.1016/j.btre.2015.08.007", "PMC4980734", "28352583"]}, {"Citation": "Zhang L, Zhang F, Zhang W, Chen L, Gao N, Men Y, Xu X, Jiang Y. Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells. Cancer Biol Ther. 2015;16:1585\u20131592. doi: 10.1080/15384047.2015.1078021.", "ArticleIdList": ["10.1080/15384047.2015.1078021", "PMC4846143", "26382920"]}, {"Citation": "Hamsa TP, Kuttan G. Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma. Chin Med. 2011;6:11. doi: 10.1186/1749-8546-6-11.", "ArticleIdList": ["10.1186/1749-8546-6-11", "PMC3076298", "21429205"]}, {"Citation": "Song Y, Kesuma D, Wang J, Deng Y, Duan J, Wang JH, Qi RZ. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. Biochem Biophys Res Commun. 2004;317:128\u2013132. doi: 10.1016/j.bbrc.2004.03.019.", "ArticleIdList": ["10.1016/j.bbrc.2004.03.019", "15047157"]}, {"Citation": "Zou N, Wei Y, Li F, Yang Y, Cheng X, Wang C. The inhibitory effects of compound Muniziqi granule against B16 cells and harmine induced autophagy and apoptosis by inhibiting Akt/mTOR pathway. BMC Complement Altern Med. 2017;17:517. doi: 10.1186/s12906-017-2017-4.", "ArticleIdList": ["10.1186/s12906-017-2017-4", "PMC5712103", "29197358"]}, {"Citation": "Hamsa TP, Kuttan G. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Eur J Pharmacol. 2010;649:64\u201373. doi: 10.1016/j.ejphar.2010.09.010.", "ArticleIdList": ["10.1016/j.ejphar.2010.09.010", "20858484"]}, {"Citation": "Zhou X, Lei QY. Regulation of TAZ in cancer. Protein Cell. 2016;7:548\u2013561. doi: 10.1007/s13238-016-0288-z.", "ArticleIdList": ["10.1007/s13238-016-0288-z", "PMC4980330", "27412635"]}, {"Citation": "Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, Zannini M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem. 2004;279:17384\u201317390. doi: 10.1074/jbc.M312569200.", "ArticleIdList": ["10.1074/jbc.M312569200", "14970209"]}, {"Citation": "Jeong H, Bae S, An SY, Byun MR, Hwang JH, Yaffe MB, Hong JH, Hwang ES. TAZ as a novel enhancer of MyoD-mediated myogenic differentiation. FASEB J. 2010;24:3310\u20133320. doi: 10.1096/fj.09-151324.", "ArticleIdList": ["10.1096/fj.09-151324", "20466877"]}, {"Citation": "Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-\u03b2-SMAD pathway. Dev Cell. 2010;19:831\u2013844. doi: 10.1016/j.devcel.2010.11.012.", "ArticleIdList": ["10.1016/j.devcel.2010.11.012", "21145499"]}, {"Citation": "Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol. 2003;23:1004\u20131013. doi: 10.1128/MCB.23.3.1004-1013.2003.", "ArticleIdList": ["10.1128/MCB.23.3.1004-1013.2003", "PMC140696", "12529404"]}, {"Citation": "Mahoney WM, Jr, Hong JH, Yaffe MB, Farrance IK. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J. 2005;388:217\u2013225. doi: 10.1042/BJ20041434.", "ArticleIdList": ["10.1042/BJ20041434", "PMC1186710", "15628970"]}, {"Citation": "Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309:1074\u20131078. doi: 10.1126/science.1110955.", "ArticleIdList": ["10.1126/science.1110955", "16099986"]}, {"Citation": "Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, Xiong Y, Lei QY, Guan KL. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem. 2009;284:13355\u201313362. doi: 10.1074/jbc.M900843200.", "ArticleIdList": ["10.1074/jbc.M900843200", "PMC2679435", "19324877"]}, {"Citation": "Hong JH, Yaffe MB. TAZ: A beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle. 2006;5:176\u2013179. doi: 10.4161/cc.5.2.2362.", "ArticleIdList": ["10.4161/cc.5.2.2362", "16397409"]}, {"Citation": "Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene. 2011;30:2181\u20132186. doi: 10.1038/onc.2010.606.", "ArticleIdList": ["10.1038/onc.2010.606", "21258416"]}, {"Citation": "Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One. 2013;8:e65539. doi: 10.1371/journal.pone.0065539.", "ArticleIdList": ["10.1371/journal.pone.0065539", "PMC3677905", "23762387"]}, {"Citation": "Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25:2594\u20132609. doi: 10.1101/gad.176800.111.", "ArticleIdList": ["10.1101/gad.176800.111", "PMC3248681", "22190458"]}, {"Citation": "Zhou X, Wang S, Wang Z, Feng X, Liu P, Lv XB, Li F, Yu FX, Sun Y, Yuan H, et al. Estrogen regulates Hippo signaling via GPER in breast cancer. J Clin Invest. 2015;125:2123\u20132135. doi: 10.1172/JCI79573.", "ArticleIdList": ["10.1172/JCI79573", "PMC4463207", "25893606"]}, {"Citation": "Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u2013772. doi: 10.1016/j.cell.2011.09.048.", "ArticleIdList": ["10.1016/j.cell.2011.09.048", "22078877"]}, {"Citation": "Yang N, Morrison CD, Liu P, Miecznikowski J, Bshara W, Han S, Zhu Q, Omilian AR, Li X, Zhang J. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle. 2012;11:2922\u20132930. doi: 10.4161/cc.21386.", "ArticleIdList": ["10.4161/cc.21386", "PMC3419062", "22825057"]}, {"Citation": "Xu W, Wei Y, Wu S, Wang Y, Wang Z, Sun Y, Cheng SY, Wu J. Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib. Cell Biosci. 2015;5:7. doi: 10.1186/2045-3701-5-7.", "ArticleIdList": ["10.1186/2045-3701-5-7", "PMC4429831", "25973173"]}, {"Citation": "Yuen HF, McCrudden CM, Huang YH, Tham JM, Zhang X, Zeng Q, Zhang SD, Hong W. TAZ expression as a prognostic indicator in colorectal cancer. PLoS One. 2013;8:e54211. doi: 10.1371/journal.pone.0054211.", "ArticleIdList": ["10.1371/journal.pone.0054211", "PMC3553150", "23372686"]}, {"Citation": "Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W. A role for TAZ in migration, invasion, and tumori-genesis of breast cancer cells. Cancer Res. 2008;68:2592\u20132598. doi: 10.1158/0008-5472.CAN-07-2696.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2696", "18413727"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK, Liu K, Huang S. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res. 2009;69:9228\u20139235. doi: 10.1158/0008-5472.CAN-09-1950.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1950", "PMC2795125", "19920183"]}, {"Citation": "Pal I, Mandal M. PI3K and Akt as molecular targets for cancer therapy: Current clinical outcomes. Acta Pharmacol Sin. 2012;33:1441\u20131458. doi: 10.1038/aps.2012.72.", "ArticleIdList": ["10.1038/aps.2012.72", "PMC4001841", "22983389"]}, {"Citation": "Geng X, Ren Y, Wang F, Tian D, Yao X, Zhang Y, Tang J. Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy. Biochem Biophys Res Commun. 2018;498:99\u2013104. doi: 10.1016/j.bbrc.2018.02.205.", "ArticleIdList": ["10.1016/j.bbrc.2018.02.205", "PMC5857254", "29501493"]}, {"Citation": "Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao XL, Pan YL, Jiang JW. Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary Pancreat Dis Int. 2011;10:599\u2013604. doi: 10.1016/S1499-3872(11)60102-1.", "ArticleIdList": ["10.1016/S1499-3872(11)60102-1", "22146623"]}, {"Citation": "Uhl KL, Schultz CR, Geerts D, Bachmann AS. Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma. Cancer Cell Int. 2018;18:82. doi: 10.1186/s12935-018-0574-3.", "ArticleIdList": ["10.1186/s12935-018-0574-3", "PMC5992763", "29977157"]}, {"Citation": "Sasaki H. Roles and regulations of Hippo signaling during preimplantation mouse development. Dev Growth Differ. 2017;59:12\u201320. doi: 10.1111/dgd.12335.", "ArticleIdList": ["10.1111/dgd.12335", "28035666"]}, {"Citation": "He J, Bao Q, Yan M, Liang J, Zhu Y, Wang C, Ai D. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease. Br J Pharmacol. 2018;175:1354\u20131361. doi: 10.1111/bph.13806.", "ArticleIdList": ["10.1111/bph.13806", "PMC5866970", "28369744"]}, {"Citation": "Patel SH, Camargo FD, Yimlamai D. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis. Gastroenterology. 2017;152:533\u2013545. doi: 10.1053/j.gastro.2016.10.047.", "ArticleIdList": ["10.1053/j.gastro.2016.10.047", "PMC5285449", "28003097"]}, {"Citation": "Gregorieff A, Wrana JL. Hippo signalling in intestinal regeneration and cancer. Curr Opin Cell Biol. 2017;48:17\u201325. doi: 10.1016/j.ceb.2017.04.005.", "ArticleIdList": ["10.1016/j.ceb.2017.04.005", "28527754"]}, {"Citation": "Watt KI, Harvey KF, Gregorevic P. Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway. Front Physiol. 2017;8:942. doi: 10.3389/fphys.2017.00942.", "ArticleIdList": ["10.3389/fphys.2017.00942", "PMC5705614", "29225579"]}, {"Citation": "Kim W, Jho EH. The history and regulatory mechanism of the Hippo pathway. BMB Rep. 2018;51:106\u2013118. doi: 10.5483/BMBRep.2018.51.3.022.", "ArticleIdList": ["10.5483/BMBRep.2018.51.3.022", "PMC5882217", "29397869"]}, {"Citation": "Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Harada T, Gangeswaran R, Manson-Bishop C, Smith P, Danovi SA, et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ. 2008;15:1752\u20131759. doi: 10.1038/cdd.2008.108.", "ArticleIdList": ["10.1038/cdd.2008.108", "18617895"]}, {"Citation": "Yu X, Long YC, Shen HM. Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy. Autophagy. 2015;11:1711\u20131728. doi: 10.1080/15548627.2015.1043076.", "ArticleIdList": ["10.1080/15548627.2015.1043076", "PMC4824607", "26018563"]}, {"Citation": "Tang D, Chen QB, Xin XL, Aisa HA. Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanism via PI3K/Akt signaling pathway. Biomed Pharmacother. 2017;87:145\u2013152. doi: 10.1016/j.biopha.2016.12.058.", "ArticleIdList": ["10.1016/j.biopha.2016.12.058", "28049096"]}, {"Citation": "Lynch JT, McEwen R, Crafter C, McDermott U, Garnett MJ, Barry ST, Davies BR. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128\u201322139. doi: 10.18632/oncotarget.8031.", "ArticleIdList": ["10.18632/oncotarget.8031", "PMC5008349", "26989080"]}, {"Citation": "Li YH, Fu HL, Tian ML, Wang YQ, Chen W, Cai LL, Zhou XH, Yuan HB. Neuron-derived FGF10 ameliorates cerebral ischemia injury via inh+ibiting NF-\u03baB-dependent neuroinflammation and activating PI3K/Akt survival signaling pathway in mice. Sci Rep. 2016;6:19869. doi: 10.1038/srep19869.", "ArticleIdList": ["10.1038/srep19869", "PMC4728497", "26813160"]}, {"Citation": "Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K. Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res. 2012;31:30. doi: 10.1186/1756-9966-31-30.", "ArticleIdList": ["10.1186/1756-9966-31-30", "PMC3351370", "22463874"]}, {"Citation": "Roos DH, Puntel RL, Lugokenski TH, Ineu RP, Bohrer D, Burger ME, Franco JL, Farina M, Aschner M, Rocha JB, et al. Complex methylmercury-cysteine alters mercury accumulation in different tissues of mice. Basic Clin Pharmacol Toxicol. 2010;107:789\u2013792. doi: 10.1111/j.1742-7843.2010.00577.x.", "ArticleIdList": ["10.1111/j.1742-7843.2010.00577.x", "20486922"]}]}], "History": [{"Year": "2018", "Month": "10", "Day": "26"}, {"Year": "2019", "Month": "3", "Day": "27"}, {"Year": "2019", "Month": "5", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31081045", "PMC6521938", "10.3892/ijo.2019.4777"]}}]}